Anesth Pain Med.
2011 Jul;6(3):203-211.
Dexmedetomidine in neurosurgical anesthesia
- Affiliations
-
- 1Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, College of Medicine, Inje University, Seoul, Korea. yonjh@ paik.ac.kr
Abstract
- Dexmedetomidine is a new selective alpha2-adrenoreceptor agonist that can be described as a useful, safe adjunct in neuroanesthesia and neurocritical care practice. This alpha2-adrenoreceptor agonist offers a unique "cooperative sedation" +/- anxiolysis and analgesia without respiratory depression. Cerebral effects are generally consistent with a desirable neurophysiological profile, including neuroprotective characteristics. In addition, sympatholytic and antinociceptive properties allow for hemodynamic stability at critical moments of neurosurgical stimulation. This paper reviews the pharmacokinetic profiles and current clinical uses of dexmedetomidine in the area of neurosurgery patient care.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Dexmedetomidine: an attractive adjunct to anesthesia
- Remifentanil or dexmedetomidine for monitored anesthesia care during cataract surgery under topical anesthesia
- Clinical use of dexmedetomidine in monitored anesthesia care
- Effect of Dexmedetomidine on the Corrected QT and Tp-e Intervals during Spinal Anesthesia
- Dexmedetomidine for Repeated Sedation in Pediatric Sedation During Consecutive Radiation Therapy
